Juno halts planned sale of Velcade generic in settlement with Millennium, US
Biopharmalex 2020-03-24 11:08 am By Christine Caulfield | Melbourne
Please login to bookmark Close

Generic drug maker Juno Pharmaceuticals has agreed to stopped planned sales of its cheap version of Millennium Pharmaceuticals anti-cancer medication Velcade in Australia as part of a settlement of its lawsuit alleging two patents covering the drug were invalid.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au